Thymopoietin: Difference between revisions
CSV import |
CSV import Tag: Reverted |
||
| Line 31: | Line 31: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Revision as of 01:32, 18 March 2025
Thymopoietin (also known as TMPO, LAP2, or Lamina-associated polypeptide 2) is a protein that in humans is encoded by the TMPO gene. It is a critical component of the nuclear structure and plays a vital role in cell division and cell cycle regulation.
Function
Thymopoietin is involved in the regulation of the cell cycle, specifically during the G2/M transition. It interacts with B-type lamins, which are integral components of the nuclear envelope. This interaction is crucial for the structural integrity of the nuclear envelope and the successful completion of cell division.
Clinical significance
Alterations in the expression or function of thymopoietin have been associated with several diseases. For example, mutations in the TMPO gene have been linked to Barth syndrome, a rare genetic disorder characterized by cardiomyopathy, neutropenia, and muscle weakness. Additionally, overexpression of thymopoietin has been observed in certain types of cancer, suggesting a potential role in tumorigenesis.
Research
Research into thymopoietin has provided valuable insights into the mechanisms of cell division and the pathogenesis of various diseases. It has potential therapeutic implications, particularly in the treatment of diseases associated with cell cycle dysregulation, such as cancer.
See also
References